The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. | Trump's appointment follows his ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

Revenue: US$2.73m (down 33% from 3Q 2023). Net loss: US$162.0m (loss narrowed by 8.5% from 3Q 2023). US$0.86 loss per share ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

A ‘Unified Digital Pharmacy Platform’ (UDPP) could serve as a digital healthcare solution for senior citizens, eliminating ...

Q2 Results Review: 66% of companies reported EPS downgrades for FY25. Among these, 40% saw EPS reductions exceeding 3%, 29% ...